MA
RGNX icon

MUFG Americas’s Regenxbio RGNX Stock Holding History

MUFG Americas’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-473
Closed -$36K – 784
2018
Q3 		$36K Hold
473
– – ﹤0.01% 563
2018
Q2 		$34K Hold
473
– – ﹤0.01% 589
2018
Q1 		$14K Sell
473
-155
-25% -$4.51K ﹤0.01% 723
2017
Q4 		$21K Sell
628
-200
-24% -$6.03K ﹤0.01% 731
2017
Q3 		$27K Buy
828
+18
+2% +$405 ﹤0.01% 670
2017
Q2 		$16K Buy
810
+5
+0.6% +$97 ﹤0.01% 758
2017
Q1 		$16K Buy
805
+144
+22% +$2.78K ﹤0.01% 765
2016
Q4 		$12K Buy
+661
New +$12.6K ﹤0.01% 811

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
WM
WS Management Jacksonville, Florida $1.14B AUM 139.27% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

MUFG Americas's RGNX Position: Q4 2018 in Review

MUFG Americas sold out of Regenxbio (RGNX) in Q4 2018, closing a stake of 473 shares — an estimated $36K sold.

MUFG Americas first reported a position in RGNX in Q4 2016 and held it in 8 quarters. The position peaked at $36K in Q3 2018. 183 funds tracked by Wall St. Rank hold RGNX as of Q4 2018.

  • MUFG Americas reported no remaining Regenxbio position as of Q4 2018 after selling out during the quarter.
  • MUFG Americas sold 473 Regenxbio shares in Q4 2018, an estimated $36K.
  • MUFG Americas first reported a position in Regenxbio in Q4 2016 and held it in 8 quarters.
  • MUFG Americas's Regenxbio position peaked at $36K in Q3 2018.
  • 183 funds tracked by Wall St. Rank held Regenxbio as of Q4 2018.

Based on MUFG Americas's 13F filing for Q4 2018, filed 13 Feb 2019.